- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Neoimmunetech Inc DRC (950220)
Track today's live Neoimmunetech (950220) share price, performance and key data on this page with our current KOSDAQ:950220 stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Neoimmunetech share price on the KOSDAQ exchange. Use the dropdown to switch exchange for the 950220 share price, head to our technical summary section, which provides analysis on Neoimmunetech share price buy/sell indicators using real-time data (or discuss the Neoimmunetech (950220) stock price today with other investors in the Neoimmunetech KQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current KQ:950220 share price (ISIN: KR8840140006) to enhance your trading decisions with our free investment tools and resources.
What Is the Neoimmunetech Inc DRC Share Price Today?
The Neoimmunetech share price today is 1,317.
What Is the Stock Symbol for Neoimmunetech Inc DRC
The stock symbol (or 'ticker') for Neoimmunetech Inc DRC is "950220."
What Stock Exchange Does Neoimmunetech Inc DRC Trade On?
Neoimmunetech Inc DRC is listed and trades on the KOSDAQ stock exchange.
Is Neoimmunetech Inc DRC a Good Stock to Buy?
Determining whether Neoimmunetech (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current KQ:950220 share price (ISIN: KR8840140006) to enhance your trading decisions with our free investment tools and resources.
What Is the Neoimmunetech Inc DRC Share Price Today?
The Neoimmunetech share price today is 1,317.
What Is the Stock Symbol for Neoimmunetech Inc DRC
The stock symbol (or 'ticker') for Neoimmunetech Inc DRC is "950220."
What Stock Exchange Does Neoimmunetech Inc DRC Trade On?
Neoimmunetech Inc DRC is listed and trades on the KOSDAQ stock exchange.
Is Neoimmunetech Inc DRC a Good Stock to Buy?
Determining whether Neoimmunetech (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
KOSDAQ
Currency in KRW
1,317
+17(+1.31%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,235
1,320
52 wk Range
367
2,150
950220 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,2351,320
52 wk Range
3672,150
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
950220 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Earnings
Latest Release
15/05/2026
EPS / Forecast
-46.80 / --
Revenue / Forecast
526.98M / --
Compare 950220 to Peers and Sector
Metrics to compare | 950220 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship950220PeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.1x | −4.0x | −0.4x | |
PEG Ratio | −0.11 | −0.03 | 0.00 | |
Price/Book | 2.4x | 1.3x | 2.6x | |
Price / LTM Sales | 211.2x | 7.8x | 3.0x | |
Upside (Analyst Target) | - | 291.8% | 54.6% | |
Fair Value Upside | Unlock | 11.3% | 9.7% | Unlock |
NeoImmuneTech, Inc., a clinical-stage T cell-based biotechnology company, develops and sells immuno-therapeutics in Korea. It is developing NT-I7, an IL-7 class T- cell amplifier to treat acute radiation syndrome; and Heterodimer hybrid Fc platform, an antibody platform technology, as well as NT2020, a T cell activator; NT3020, a T cell engager; NT4010, an advanced CAR-T; and NT5010, a TME modifier. The company was incorporated in 2014 and is headquartered in Rockville, Maryland.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Neoimmunetech (KOSDAQ: 950220) Share Price Today?
The Neoimmunetech stock price today is 1,317 KRW.
What Stock Exchange Does Neoimmunetech (950220) Trade On?
Neoimmunetech is listed and trades on the KOSDAQ.
What Is the Ticker (Stock Symbol) for Neoimmunetech?
The stock symbol (also called a 'ticker') for Neoimmunetech is "950220."
What Is the Current Neoimmunetech Market Capitalisation?
As of today, Neoimmunetech (KOSDAQ: 950220) market cap is 128.53B KRW.
What Is Neoimmunetech's (950220) Earnings Per Share (TTM)?
The Neoimmunetech EPS is currently -233 (Trailing Twelve Months).
Is 950220 a Buy or Sell From a Technical Analyst Perspective?
Based on today's Neoimmunetech moving averages and other technical indicators, the daily buy/sell signal for 950220 stock is Buy.
How Many Times Has Neoimmunetech Stock Split?
Neoimmunetech has split 1 times. (See the 950220 stock split history page for full effective split date and price information.)
How Many Employees Does Neoimmunetech Have?
Neoimmunetech has 52 employees, based on their latest Companies House report.
What is the current trading status of Neoimmunetech (KOSDAQ: 950220)?
As of 21/07/2026, Neoimmunetech (950220) is trading at a share price of 1,317 KRW, with a previous close of 1,300 KRW. The stock has fluctuated within a day range of 1,235 KRW to 1,320 KRW, while its 52-week range spans from 367 KRW to 2,150 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.